Pharmaceuticals
The pharmaceutical industry is a EUR 1 trillion sector and has been a major engine of economic growth and scientific advancement for decades. The industry encompasses a wide range of enterprises including large ethical drug multi-nationals (so-called Big Pharma), mid-sized specialty pharmaceutical companies, generic manufacturers, virtual pharmas, small biotechnology and biopharmaceutical firms, and all the various ancillary support and service companies that provide contract research, regulatory guidance, contract sales, and manufacturing technologies and raw materials.
Although growth has not been as robust in recent years—mainly due to price pressures, uncertainty in regulatory/reform measures, and weak drug pipelines— the demographic and structural drivers of demand in healthcare still exist: namely, the continued aging of the global population and the increasing sophistication and wealth of developing nations. Shifting epidemiology patterns and outbreaks, along with new challenges in chronic disease, cancer, heart disease, and degenerative disease will continue to impel the need for ever-better medicines. New understanding and technologies in drug delivery, and most especially in the fields of genomics, proteomics, and molecular biology generally, also hold promise for better therapeutics and a revival of profits.
Although growth has not been as robust in recent years—mainly due to price pressures, uncertainty in regulatory/reform measures, and weak drug pipelines— the demographic and structural drivers of demand in healthcare still exist: namely, the continued aging of the global population and the increasing sophistication and wealth of developing nations. Shifting epidemiology patterns and outbreaks, along with new challenges in chronic disease, cancer, heart disease, and degenerative disease will continue to impel the need for ever-better medicines. New understanding and technologies in drug delivery, and most especially in the fields of genomics, proteomics, and molecular biology generally, also hold promise for better therapeutics and a revival of profits.
Page 4/16
Dr. Reddy's Laboratories, Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
July 2013 · MarketLine
Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00
Siemens Healthcare - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
July 2013 · MarketLine
Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00
Cardinal Health, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
July 2013 · MarketLine
Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00
Actavis Group hf (formerly Pharmaco Hf) - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
July 2013 · MarketLine
Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00
Fresenius Kabi AG - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
July 2013 · MarketLine
Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00
Novozymes A/S - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
July 2013 · MarketLine
Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00
Nycomed International Management GmbH - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
July 2013 · MarketLine
Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00
BTG plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
July 2013 · MarketLine
Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00
Phosphagenics Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
July 2013 · MarketLine
Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00
Novartis Vaccines and Diagnostics, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
July 2013 · MarketLine
Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00
Glenmark Generics, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
July 2013 · MarketLine
Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00
Takeda Pharmaceuticals North America, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
July 2013 · MarketLine
Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00
ImmuneRegen BioSciences, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
July 2013 · MarketLine
Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00
SAIC-Frederick, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
July 2013 · MarketLine
Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00
Immunomedics, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
July 2013 · MarketLine
Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00
Ipsogen SA - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
July 2013 · MarketLine
Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00
Genetic Technologies Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
July 2013 · MarketLine
Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00
Warner Chilcott Plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
July 2013 · MarketLine
Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00
PTC Therapeutics, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
July 2013 · MarketLine
Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00
Fluidigm Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
July 2013 · MarketLine
Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00
BG Medicine, Inc. (formerly Beyond Genomics, Inc.) - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
July 2013 · MarketLine
Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00
Champions Oncology, Inc. (formerly Champions Biotechnology, Inc.) - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
July 2013 · MarketLine
Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00
Immunocellular Therapeutics, Ltd. (formerly Optical Molecular Imaging, Inc.) - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
July 2013 · MarketLine
Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00
Oragenics, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
July 2013 · MarketLine
Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00
Vical, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
July 2013 · MarketLine
Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00
Cellular Dynamics International, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
July 2013 · MarketLine
Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00
Radius Health, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
July 2013 · MarketLine
Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00
Sangamo BioSciences, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
July 2013 · MarketLine
Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00
OncoMed Pharmaceuticals, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
July 2013 · MarketLine
Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00
Compugen, Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
July 2013 · MarketLine
Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00
OctoPlus N.V. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
July 2013 · MarketLine
Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00
Regulus Therapeutics, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
July 2013 · MarketLine
Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00
Rigel Pharmaceuticals, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
July 2013 · MarketLine
Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00
Rexahn Pharmaceuticals, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
July 2013 · MarketLine
Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00
Profectus BioSciences, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
July 2013 · MarketLine
Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00
Micromet, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
July 2013 · MarketLine
Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00
Complete Genomics, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
July 2013 · MarketLine
Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00
WaferGen Bio-systems, Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
July 2013 · MarketLine
Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00
Seattle Genetics, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
July 2013 · MarketLine
Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00
Anacor Pharmaceuticals, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
July 2013 · MarketLine
Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00
GenVec, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
July 2013 · MarketLine
Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00
Exelixis, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
July 2013 · MarketLine
Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00
Celsion Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
July 2013 · MarketLine
Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00
Patheon, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
July 2013 · MarketLine
Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00
Amsterdam Molecular Therapeutics (AMT) Holding N.V. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
July 2013 · MarketLine
Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00
InterMune, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
July 2013 · MarketLine
Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00
QRxPharma Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
July 2013 · MarketLine
Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00
Ambit Biosciences Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
July 2013 · MarketLine
Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00
Novavax, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
July 2013 · MarketLine
Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00
Labopharm, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
July 2013 · MarketLine
Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00
Options